Skip to main content
. 2018 Apr 18;10(4):123. doi: 10.3390/cancers10040123
10FoldCV repeated 10-fold cross validation
ACN acetonitrile
AUC accuracy
BC bladder cancer
BHP benign prostate hypertrophy
CI confidence interval
DDLLME dispersive derivatisation liquid–liquid microextraction
DMF dimethylformamide
DoubleCV double cross validation
DRE digital rectal examination
EN electronic nose
ESI electrospray ionisation
GC-MS gas chromatography-mass spectrometry
GS Gleason score
LC-MS liquid chromatography-mass spectrometry
LDA linear discriminant analysis
LOOCV leave one out cross validation
MAD microwave assisted derivatisation
MOS metal oxide semiconductors
PBs transrectal ultrasound-guided prostate biopsy
PCa prostate cancer
PCA principal component analysis
PLS-DA partial least squares discriminant analysis
PSA prostate specific antigen
Put putrescine
RF random forest
ROC receiver operating characteristics
Spd spermidine
Spm spermine
SPME solid phase microextraction
SVM support vector machine
SVM-P Support vector machine-polynomial
UPLC ultra-high performance liquid chromatography
VOCs volatile organic compounds